Key Takeaways
Is Anxiety Depression? The Short Answer
The belief that anxiety is depression in another form does not match how either condition is diagnosed. Anxiety disorders center on fear and worry that is intense and excessive[5]. Depression centers on low mood or lost interest lasting most of the day, nearly every day, for at least 2 weeks[6].
The two are still closely linked. Depression’s own symptom list includes a persistent “sad, anxious, or empty” mood, and people with depression often also have generalized anxiety disorder, social phobia or panic disorder[6]. Anxiety disorders, in turn, increase the risk of developing depression[5].
The accurate framing is two distinct diagnoses that share symptoms, genetic risk and a core of emotional distress. Both are common: WHO estimates that 5.8% of the world’s population, about 470 million people in 2023, had an anxiety disorder[5], and that 5.2% of adults have depression[7].
Prevalence by year, state and population is tracked on the major depressive disorder and generalized anxiety disorder pages. This article covers how the two are told apart and why they are so often confused.
How DSM-5 and ICD-11 Classify Anxiety and Depression
The American Psychiatric Association’s DSM-5, released in May 2013, places major depressive disorder in a “depressive disorders” class and generalized anxiety disorder in a separate “anxiety disorders” class[1]. DSM-IV had grouped depression with bipolar disorder under “mood disorders,” and DSM-5 split that group in two, while anxiety disorders kept their own class in both editions[1].
DSM-5 handles the overlap with a label rather than a merged diagnosis. A major depressive episode can carry the specifier “with anxious distress” when anxiety symptoms accompany it[2].
The WHO’s ICD-11 takes a similar approach. Depressive episodes can be coded “with prominent anxiety symptoms” or “with panic attacks,” and the depressive disorders group also holds a separate code, 6A73, for mixed depressive and anxiety disorder[8].
That mixed category is where the line between the two conditions is hardest to hold. When a mixed anxiety-depressive disorder was tested in the DSM-5 field trials, two clinicians assessing the same patients agreed on it no better than chance, with a pooled kappa of −0.004[3].
Agreement was only modest for the established diagnoses too: a pooled kappa of 0.28 for major depressive disorder across four sites and 0.20 for generalized anxiety disorder at a single site[3]. Symptoms that sit between anxiety and depression are hard to classify consistently, which is different from the two conditions being identical.
DSM-5 Field Trial Reliability: Depression, Anxiety and the Mixed Diagnosis
| Diagnosis | Kappa | Authors’ rating | Test sites |
|---|---|---|---|
| Major depressive disorder | 0.28 | Questionable | 4 |
| Generalized anxiety disorder | 0.20 | Questionable | 1 |
| Mixed anxiety-depressive disorder (proposed) | −0.004 | Unacceptable | 2 |
Test-retest agreement (intraclass kappa, pooled where tested at more than one site) between two clinicians in the DSM-5 field trials in the United States and Canada, published 2013[3].
1The field-trial authors rated kappa values of 0.20 to 0.39 as questionable and values below 0.20 as unacceptable[3].
2Generalized anxiety disorder was tested at one site (Penn) and the mixed diagnosis at two (Penn and UCLA)[3].
Sources
- •Regier DA, et al., American Journal of Psychiatry, 2013
What Separates Anxiety From Depression?
The diagnostic thresholds differ. A depression diagnosis requires symptoms most of the day, nearly every day, for at least 2 weeks[6]. Generalized anxiety disorder requires hard-to-control worry on most days for at least 6 months, plus at least three of six symptoms such as restlessness, fatigue or muscle tension[9].
Several symptoms appear on both NIMH lists: restlessness or feeling on edge, irritability, fatigue, trouble concentrating and sleep problems[6][9]. That shared ground is a main reason the two are confused.
The distinguishing features sit elsewhere. Depression’s list includes loss of interest or pleasure, hopelessness, and guilt or worthlessness[6]. The generalized anxiety disorder list includes excessive worry about everyday things, trembling, sweating and feeling out of breath[9].
The tripartite model
Researchers Clark and Watson formalized this pattern in 1991[10]. Their tripartite model proposes a component of general distress shared by both conditions, physiological hyperarousal specific to anxiety, and anhedonia (loss of pleasure) specific to depression[10].
The common description of anxiety as a high-energy state and depression as a low-energy one is a loose version of that split between hyperarousal and anhedonia[10]. It breaks down for individuals, since restlessness and fatigue appear on the symptom lists for both[6][9].
A side-by-side symptom table is in Depression and Anxiety: How Often They Overlap and Why. The full criteria are covered in GAD DSM-5 criteria and signs and symptoms of depression.
Is Anxiety a Symptom of Depression?
Often, yes, and the diagnostic manuals account for it. NIMH lists an anxious mood among the signs of depression[6], and DSM-5 lets clinicians mark a depressive episode “with anxious distress”[2].
The specifier requires at least 2 of 5 symptoms: feeling keyed up or tense, unusual restlessness, trouble concentrating because of worry, fear that something awful will happen, and a sense of possibly losing control[2].
In the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III), which interviewed 36,309 U.S. adults, the anxious distress specifier described 74.6% of people with lifetime major depressive disorder[2]. The survey counted symptoms present for at least 2 weeks rather than on more days than not, a lower bar than the manual sets, so the figure may overstate the share under strict criteria[2].
Anxious depression is still depression. The anxiety describes how the episode presents. When a separate anxiety disorder is present, such as generalized anxiety disorder or panic disorder, it is a second condition alongside the depression[6].
U.S. adults with lifetime major depression whose episodes met the DSM-5 anxious distress specifier, 2012-2013
About three in four people with major depression in a national survey of 36,309 adults had marked anxiety during their episodes. The survey used a shorter duration threshold than DSM-5 itself.
"The anxious/distressed specifier characterized 74.6% of MDD cases"
Anxious distress (DSM-5 specifier)
A label added to a depressive episode when at least 2 of 5 anxiety symptoms are present: feeling keyed up or tense, unusual restlessness, trouble concentrating because of worry, fear that something awful may happen, and feeling one might lose control[2]. It describes how a depression presents and is not a separate diagnosis.
Related Terms
Source: DSM-5, as summarized in Hasin DS, et al., JAMA Psychiatry, 2018
Can Anxiety Turn Into Depression?
Anxiety does not convert into depression, but it is associated with a higher risk of developing it. WHO states that anxiety disorders increase the risk for depression, substance use disorders and suicidal thoughts and behaviours[5].
NIMH similarly reports that some people with generalized anxiety disorder also have depression[9]. Because the two share genetic risk[4], a person who develops one and then the other may be showing a common vulnerability rather than one illness causing the next.
Which condition tends to appear first, and how often they co-occur, is covered with survey data in the depression and anxiety overlap article. Population-level figures are on the comorbidity page.
Are Anxiety and Depression Treated the Same Way?
Some treatments overlap, which adds to the impression that the two are one condition. Escitalopram (Lexapro), a selective serotonin reuptake inhibitor, is FDA-approved for major depressive disorder in adults and adolescents 12 and older and for generalized anxiety disorder in adults and children 7 and older[12].
A medication that treats both does not make them a single diagnosis. The label lists major depressive disorder and generalized anxiety disorder as separate indications with different minimum ages[12].
Trial evidence for each condition is reviewed in anxiety medication and anti-depression meds.
Frequently Asked Questions
Sources & References
- Substance Abuse and Mental Health Services Administration. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. SAMHSA. Published 2016. Accessed October 2026. https://www.samhsa.gov/data/sites/default/files/NSDUH-DSM5ImpactAdultMI-2016.pdf [Link]
- Hasin DS, Sarvet AL, Meyers JL, et al. Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States. JAMA Psychiatry. Published 2018. Accessed October 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC5875313/ [Link]
- Regier DA, Narrow WE, Clarke DE, et al. DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses. American Journal of Psychiatry. Published 2013. Accessed October 2026. https://psychiatryonline.org/doi/10.1176/appi.ajp.2012.12070999 [Link]
- Kendler KS, Gardner CO, Gatz M, Pedersen NL. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychological Medicine. Published 2007. Accessed October 2026. https://www.cambridge.org/core/journals/psychological-medicine/article/abs/sources-of-comorbidity-between-major-depression-and-generalized-anxiety-disorder-in-a-swedish-national-twin-sample/92ACB40971A19439A35F4024CC3E3285 [Link]
- World Health Organization. Anxiety disorders. World Health Organization. Published 2026. Accessed October 2026. https://www.who.int/news-room/fact-sheets/detail/anxiety-disorders [Link]
- National Institute of Mental Health. Depression. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/publications/depression [Link]
- World Health Organization. Depressive disorder (depression). World Health Organization. Published 2026. Accessed October 2026. https://www.who.int/news-room/fact-sheets/detail/depression [Link]
- World Health Organization. Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders (CDDR). World Health Organization. Published 2024. Accessed October 2026. https://iris.who.int/bitstream/handle/10665/375767/9789240077263-eng.pdf [Link]
- National Institute of Mental Health. Generalized Anxiety Disorder: What You Need to Know. National Institutes of Health. Published 2025. Accessed October 2026. https://www.nimh.nih.gov/health/publications/generalized-anxiety-disorder-gad [Link]
- Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. Journal of Abnormal Psychology. Published 1991. Accessed October 2026. https://psycnet.apa.org/doiLanding?doi=10.1037%2F0021-843X.100.3.316 [Link]
- Friligkou E, Løkhammer S, Cabrera-Mendoza B, et al. Gene discovery and biological insights into anxiety disorders from a large-scale multi-ancestry genome-wide association study. Nature Genetics. Published 2024. Accessed October 2026. https://www.nature.com/articles/s41588-024-01908-2 [Link]
- U.S. Food and Drug Administration. Lexapro (escitalopram) prescribing information. U.S. Food and Drug Administration. Published 2023. Accessed October 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021323s055,021365s039lbl.pdf [Link]